Faron Pharmaceuticals outlines groundbreaking work in cancer treatment - Markku Jalkanen, CEO of Faron Pharmaceuticals Limited 00:00:00

Share On Facebook Share On Twitter

Dr. Markku Jalkanen, CEO of Faron Pharmaceuticals Limited, delivered a pivotal presentation on the company's groundbreaking work in cancer treatment, focusing on the reprogramming of myeloid cells to combat cancer at the Proactive One2One Investor Conference.

Recent Videos